593
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Myoglobin does not predict local toxicity in isolated limb perfusion

, & ORCID Icon
Pages 679-683 | Received 22 Oct 2016, Accepted 15 Mar 2017, Published online: 10 Apr 2017

References

  • Abbott AM, Zager JS. (2014). Locoregional therapies in melanoma. Surg Clin North Am 94:1003–15, viii.
  • Creech O, Krementz ET, Ryan RF, Winblad JN. (1958). Chemotherapy of Cancer: Regional Perfusion Utilizing an Extracorporeal Circuit. Ann Surg 148:616–32.
  • Perry MC, Doll DC, Freter CE. Perry's the chemotherapy source book. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.
  • Wieberdink J, Benckhuysen C, Braat RP, et al. (1982). Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18:905–10.
  • Neto JPD, Oliveira F, Bertolli E, et al. (2012). Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity. Clinics 67:237–41.
  • Perkoff GT. (1965). Myoglobin. Am J Med 39:527–32.
  • Hohenberger P, Haier J, Schlag PM. (1997). Rhabdomyolysis and renal function impairment after isolated limb perfusion: comparison between the effects of perfusion with rhTNFα and a ‘triple-drug’ regimen. Eur J Cancer 33:596–601.
  • Sorichter S, Puschendorf B, Mair J. (1999). Skeletal muscle injury induced by eccentric muscle action: muscle proteins as markers of muscle fiber injury. Exercise Immunol Rev 5:5–21.
  • Hohenberger P, Haier J, Kettelhack C, et al. (1997). Erfassung regionaler und systemischer Toxizität der isolierten, hyperthermen Extremitätenperfusion mit Tumor-Nekrose-Faktor α und Melphalan. Der Chirurg 68:914–20.
  • Möller MG, Lewis JM, Dessureault S, Zager JS. (2008). Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Int J Hypertherm 24:275–89.
  • Bonifati DM, Ori C, Rossi CR, et al. (2000). Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents. Cancer Chemother Pharmacol 46:517–22.
  • Bodié K, Buck WR, Pieh J, et al. (2016). Biomarker evaluation of skeletal muscle toxicity following clofibrate administration in rats. Exp Toxicol Pathol 68:289–99.
  • Miller Iii CC, Villa MA, Sutton J, et al. (2009). Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role? Eur J Vasc Endovasc Surg 37:388–94.
  • Premru V, Kovač J, Ponikvar R. (2013). Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury. Ther Apher Dial 17:391–5.
  • Olofsson R, Mattsson J, Lindnér P. (2013). Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma. Int J Hypertherm 29:551–7.
  • Chen IW, David R, Maxon HR, et al. (1980). Age-, sex-, and race-related differences in myoglobin concentrations in the serum of healthy persons. Clin Chem 26:1864–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.